94
|
FLT3-ITD positive
|
Acute Myeloid Leukemia (AML)
|
"" Parent
|
| | | | |
93
|
MLL-AF9 knockdown
|
Acute Myeloid Leukemia (AML)
|
"" Parent
|
| | | | |
92
|
MLL-rearrangement (MLL-AF9)
|
Acute Myeloid Leukemia (AML)
|
"" Parent
|
| | | | |
91
|
MLL–AF4 fusion gene postive
|
Acute Myeloid Leukemia (AML)
|
"" Parent
|
| | | | |
90
|
Acute promyelocytic leukaemia (APL)
|
Acute Myeloid Leukemia (AML)
|
"" Parent
|
| | | | |
89
|
Relapsed MLL-rearranged AML
|
Acute Myeloid Leukemia (AML)
|
"" Parent
|
| | | | |
88
|
C-Kit mutaion
|
Acute Myeloid Leukemia (AML)
|
"" Parent
|
| | | | |
87
|
Non-remission group after the first induction remission therapy
|
Acute Myeloid Leukemia (AML)
|
"" Parent
|
| | | | |
86
|
M4-M5 FAB subtype (Monocyte series group)
|
Acute Myeloid Leukemia (AML)
|
"" Parent
|
| | | | |
85
|
Acute promyelocytic leukaemia (APL) with t(15;17) after therapy in Complete Remission (CR)
|
Acute Myeloid Leukemia (AML)
|
"" Parent
|
| | | | |
84
|
M3 FAB subtype
|
Acute Myeloid Leukemia (AML)
|
"" Parent
|
| | | | |
83
|
M2 FAB subtype
|
Acute Myeloid Leukemia (AML)
|
"" Parent
|
| | | | |
82
|
M1 FAB subtype
|
Acute Myeloid Leukemia (AML)
|
"" Parent
|
| | | | |
81
|
Acute promyelocytic leukaemia (APL) with t(15;17) at Complete Remission (CR)
|
Acute Myeloid Leukemia (AML)
|
"" Parent
|
| | | | |
80
|
Acute promyelocytic leukaemia (APL) with t(15;17) / AML with M1, M2, M4, M5, M6 FAB subtypes
|
Acute Myeloid Leukemia (AML)
|
"" Parent
|
| | | | |
79
|
Relapsed AML with t(8;21)RUNX1/RUNX1T1
|
Acute Myeloid Leukemia (AML)
|
"" Parent
|
| | | | |
78
|
MiR-183-high/PDCD6-low
|
Acute Myeloid Leukemia (AML)
|
"" Parent
|
| | | | |
77
|
Diagnosis
|
Acute Myeloid Leukemia (AML)
|
"" Parent
|
| | | | |
76
|
GATA1 mutated myeloid leukemia-Down Syndrome (ML-DS) at diagnosis
|
Acute Myeloid Leukemia (AML)
|
"" Parent
|
| | | | |
75
|
Myeloid Leukemia-Down Syndrome (ML-DS) at diagnosis
|
Acute Myeloid Leukemia (AML)
|
"" Parent
|
| | | | |